Your browser doesn't support javascript.
loading
Efficacy of single-dose and double-dose ivermectin early treatment in preventing progression to hospitalization in mild COVID-19: A multi-arm, parallel-group randomized, double-blind, placebo-controlled trial.
Mirahmadizadeh, Alireza; Semati, Ali; Heiran, Alireza; Ebrahimi, Mostafa; Hemmati, Abdolrasool; Karimi, Mohammadreza; Basir, Souzan; Zare, Marjan; Charlys da Costa, Antonio; Zeinali, Mohammad; Sargolzaee, Maryam; Eilami, Owrang.
Afiliação
  • Mirahmadizadeh A; Non-communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Semati A; Non-communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Heiran A; Non-communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Ebrahimi M; Communicable Diseases Control Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Hemmati A; Department of Health Affairs, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Karimi M; Department of Health Affairs, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Basir S; Shiraz University of Medical Sciences, Shiraz, Iran.
  • Zare M; Non-communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Charlys da Costa A; Institute of Tropical Medicine, School of Medicine, University of São Paulo, São Paulo, Brazil.
  • Zeinali M; National Zoonoses Control Department, Ministry of Health and Medical Education, Tehran, Iran.
  • Sargolzaee M; Communicable Diseases Control Center, Ministry of Health and Medical Education, Tehran, Iran.
  • Eilami O; Department of Family Medicine and Infectious Diseases, Shiraz University of Medical Sciences, Shiraz, Iran.
Respirology ; 27(9): 758-766, 2022 09.
Article em En | MEDLINE | ID: mdl-35738778

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article